Here’s your biweekly video brief, capturing the key updates in Artificial Intelligence applications in multiple therapy areas and digital health at a glance.
🎯 Watch Our Video Summary Capturing Endocrinology News from the Last Two Weeks
Dive deeper
🗓️ Explore weekly details and sources
Week 20–27 October 2025
Week 27 October–2 November 2025
📚 Find your one-stop page for the full AI and Digital Health archive.
Top Stories Covered in This Video
Chapters
0:00 Introduction
0:12 OpenEvidence raises $200M at $6B valuation
0:31 AHA launches AI Assessment Lab with Dandelion Health
0:53 Quantum dynamics signal supports practical advantage path
1:13 METiS TechBio’s MTS-004 hits Phase 3 in China for PBA
1:59 Samsung Medical Center’s AI-driven care vision
2:23 Lilly partners with Nvidia on pharma supercomputer
2:43 Neuralink participant shares 21-month update
3:02 Microsoft and OpenAI to self-define AGI threshold
3:15 Abu Dhabi launches “Future Health” year-round platform
3:33 How to reach us
Transcript
Welcome to the latest edition of Artificial Intelligence and Digital Health Updates, covering breakthroughs in the past two weeks. Brought to you by LucidQuest.
OpenEvidence raises two hundred million dollars at a six billion dollar valuation led by GV to scale its clinician-facing tool. It is free to verified professionals and reports around fifteen million monthly clinical queries, signaling pipeline growth.
The American Heart Association and Dandelion Health launch an AI Assessment Lab to validate cardiovascular and related risk models before and after FDA review. Expert panels and proxy population datasets will support technical and economic impact reports, with post-deployment monitoring next year.
A Nature paper from Google Quantum AI measures second-order out-of-time-ordered correlators on a superconducting processor. The OTOC two signal stays sensitive at long times with constructive interference hard to classically simulate, a step toward practical advantage for biomodeling.
METiS TechBio reports Phase Three success in China for MTS-004, an AI-enabled orally disintegrating tablet for pseudobulbar affect secondary to ALS, MS, stroke, traumatic brain injury, and Parkinson’s disease, in a randomized, double-blind, placebo-controlled study of two hundred sixty-four participants. The primary endpoint was met with safety and tolerability, with improvements cited in CNS-LS, CGI-C, PGI-C, SF-36 MHI, and CNS-BFS. An NDA to the NMPA is planned for twenty twenty-six.
Samsung Medical Center details world-first HIMSS Stage Seven across EMR, imaging, analytics, and infrastructure, plus a perfect DHI score. Patient-centered programs, including robotic process automation for records and AI wound assessment, back a shift to care-at-home.
Eli Lilly partners with Nvidia to build a supercomputer using more than one thousand Blackwell B three hundred GPUs with renewable power and chilled-water cooling to accelerate discovery, trials, manufacturing, and analytics, targeting operational readiness by January.
Neuralink’s first participant, Noland Arbaugh, shares a twenty-one month update noting daily function gains, reduced direct testing as more participants enroll, and support for academic work and public speaking, with a larger update teased for early twenty twenty-six.
Microsoft and OpenAI say they will appoint an expert panel to define and adjudicate an AGI threshold, though criteria and membership are not yet specified.
Abu Dhabi’s Department of Health launches Future Health, a year-round collaboration platform converting Global Health Week into ongoing co-creation, research, and recurring dialogues, with a summit scheduled for seven to nine April twenty twenty-six at ADNEC.
Stay ahead in Artificial Intelligence and Digital Health research! Like, share, and subscribe for our updates. Visit www.lqventures.com or email us at info@lqventures.com for expert healthcare consulting. See you next time!
Why it matters
Capital flows into verticalized medical AI suggest durable demand for clinician-grade tools.
Independent validation and economic impact framing could accelerate hospital adoption of risk models.
Advances in quantum observables may eventually enable more realistic molecular and biomaterial simulations.
AI-enabled formulation success in PBA highlights speed gains for drug product design, especially for dysphagia-friendly formats.
Health systems with mature digital backbones appear best positioned for care-at-home pivots and AI workflows.
On-prem GPU capacity gives pharma control over proprietary data and model latency for discovery and trials.
Brain–computer interface progress remains patient-reported but points to functional gains and broader enrollment..
Self-defined AGI thresholds may influence governance triggers and partner contracts across the ecosystem
Year-round public–private collaboration platforms can turn events into pipelines of pilots and research outputs.
🗓️ Explore weekly details and sources
Week 20–27 October 2025
Week 27 October–2 November 2025
📚 Find your one-stop page for the full AI and Digital Health archive.
FAQ
What exactly did OpenEvidence raise, and who led the round?
$200M at a $6B valuation, led by GV, with Sequoia, Kleiner Perkins, Blackstone, Thrive, Coatue, Bond, and Craft participating.
How will AHA’s AI Assessment Lab handle validation without local data?
Dandelion will build proxy datasets reflecting target populations and deliver technical and impact reports, with post-deployment monitoring planned next year.
Did METiS disclose specific Phase 3 endpoints?
The PR states the primary endpoint was met and cites improvements in CNS-LS, CGI-C, PGI-C, SF-36 MHI, and CNS-BFS, with safety and tolerability. NDA planned for 2026.
What is unique about Lilly’s Nvidia system?
It uses >1,000 Blackwell B300 GPUs, renewable energy, and aims to accelerate discovery, trials, and operations, with targeted operational readiness by January.
Is Neuralink’s update peer-reviewed clinical data?
No. It is a participant update noting functional benefits and broader enrollment, with a tease for early 2026 news. Endpoints not specified.
What will Abu Dhabi’s Future Health do between summits?
Run co-creation programs, research, regular dialogues, and publish impact reports, focusing on longevity, resilience, digital health, and life-sciences investment.
Entities / Keywords
OpenEvidence; Google Ventures; Sequoia; Kleiner Perkins; Blackstone; Thrive Capital; Coatue; Bond; Craft | American Heart Association; Dandelion Health; cardiovascular AI; CHAI | Google Quantum AI; OTOC(2); quantum ergodicity; superconducting processor | METiS TechBio; MTS-004; Pseudobulbar Affect; NMPA; ODT | Samsung Medical Center; HIMSS Stage 7; DHI; 4-less; care-at-home | Eli Lilly; Nvidia; Blackwell B300; supercomputer | Neuralink; Noland Arbaugh; BCI | Microsoft; OpenAI; AGI panel | Department of Health – Abu Dhabi; Future Health; ADNEC.
References
- https://techcrunch.com/2025/10/20/openevidence-the-chatgpt-for-doctors-raises-200m-at-6b-valuation/
- https://www.fiercehealthcare.com/ai-and-machine-learning/hlth25-aha-unveils-ai-assessment-lab-validate-models-heart-health
- https://www.nature.com/articles/s41586-025-09526-6
- https://www.manilatimes.net/2025/10/23/tmt-newswire/pr-newswire/metis-biotech-announces-chinas-first-ai-enabled-formulation-drug-candidate-to-complete-phase-iii-clinical-trial/2207228/amp
- https://www.digitalhealthnews.com/from-4-less-to-ai-driven-care-samsung-medical-center-s-vision-for-the-next-era-of-digital-health
- https://invezz.com/news/2025/10/28/eli-lilly-partners-with-nvidia-to-build-pharma-industrys-most-powerful-ai-supercomputer/
- https://www.teslarati.com/neuralinks-first-human-patient-reflects-on-21-months-with-brain-implant-eve/
- https://the-decoder.com/microsoft-and-openai-set-their-own-rules-for-agi/
- https://gulfnews.com/uae/health/abu-dhabi-launches-future-health-to-transform-global-care-1.500330722